ILLUMINA INC (ILMN)

This CEO has battled billionaire activist Carl Icahn twice — here's his advice to Disney CEO Bob Iger

Illumina chairman and Hologic CEO Stephen MacMillan is no stranger to dealing with well-known activist investors.

Can Illumina (ILMN) Keep the Earnings Surprise Streak Alive?

Illumina (ILMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The Cathie Wood Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving

Investing with the Ark Invest guru is a roller coaster ride, but she always keeps her big ideas for the future in front of her.

Notable Tuesday Option Activity: META, ILMN, COST

Illumina Becomes Oversold (ILMN)

Nasdaq 100 Movers: TSLA, AMD

Top S&P500 movers in Monday's session

Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.

What's going on in today's session: S&P500 movers

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.

Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index.

Gapping S&P500 stocks in Monday's session

Illumina's planned divestment of GRAIL approved by the European Commission

/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has received approval of its...

UPDATE 1-EU approves Illumina's plan to divest cancer test maker Grail

U.S. gene sequencing company Illumina's plan to divest cancer diagnostic test maker Grail has received the green light from EU antitrust regulators which blocked the deal two years ago. Illumina jumped the gun in 2021 when it completed the $7.1-billion acquisition before first securing EU regulatory approval. That prompted the European Commission, which acts as the competition enforcer in the 27-country European Union, to order the company to keep Grail separate from Illumina.

UPDATE 2-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed

Illumina said on Tuesday Chief Financial Officer Joydeep Goswami will leave the gene sequencing company and be succeeded by former Summit Therapeutics' executive Ankur Dhingra. Goswami, who has more than two decades of experience in the life sciences industry, was the CFO since early 2023 and will serve as an adviser till June 30, the company said. Prior to Summit, Dhingra was the CFO at medical test maker CareDx.

Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer

/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that Joydeep Goswami has decided...

Nasdaq’s Nosebleed Section: 3 Expensive Stocks to Sell Before It’s Too Late

Investors might want to be wary and dump these expensive Nasdaq stocks to sell before their impending and potentially violent corrections.

Illumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024

/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the first quarter 2024 following the close of market on Thursday,...

ILMN May 24th Options Begin Trading

May 10th Options Now Available For Illumina (ILMN)

Why Illumina Stock Zoomed Higher on Thursday

The company's chances for winning an important legal battle have improved dramatically.

ILMN May 3rd Options Begin Trading

Nasdaq 100 Movers: PDD, MU

S&P 500 Movers: ACN, MU

UPDATE 1-Boost for Illumina as court adviser rejects EU merger powers

U.S. gene sequencing company Illumina on Thursday won the backing of an adviser to Europe's top court who said EU antitrust regulators do not have the power to scrutinise its $7.1 billion bid for Grail nor block it. The European Commission in 2021 asserted a rarely used power called Article 22 to assess the deal even though it fell short of the EU merger revenue threshold, following requests from several European Union countries. It subsequently vetoed the deal and ordered Illumina to unwind the transaction which the company had completed before securing regulatory approval, leading Illumina to file a number of challenges on various grounds.

Leading the Way: Swoop Named Provider of Choice for Employee Shuttling by Fortune 500 & Renowned Technology Companies

LOS ANGELES - March 20, 2024 - PRLog -- Swoop Inc. the leading group transportation service provider, is proud to announce its recent success in providing best-in-class employee shuttling services to renowned technology and Fortune 500 companies across the Los Angeles, San Francisco, Seattle and New York metropolitan areas. The company is transforming the daily commute for businesses across diverse sectors including tech, gaming, aerospace, retail, and media.As more companies request employees back to the office, Swoop's continued commitment to excellence in ground transportation has solidified its position as a preferred choice for corporate commute solutions in 2024."We've been working with Swoop for the last year and I currently manage the program for Illumina. We have daily employee shuttles from Bart Station/Caltrains as well as intercampus shuttles from multiple buildings. I would recommend them to any company that is looking for a scalable ground transportation program.Their customer service is unmatched, they are extremely flexible when we have last-minute needs, and they only use quality and efficient vehicles for all our routes."  -Tania S. from Illumina, Inc.Flexible, Tailor-made SolutionsSwoop scales with your specific needs. Whether you require services twice a week for 20 employees, or daily for 300 employees, the leader in group transportation services works with you to build corporate shuttle service that fits."We continue to redefine corporate commuting by providing a safe, reliable, relaxing and productive journey, allowing companies to stay competitive in these markets and attract and retain top talent." - Amir Ghorbani, Founder & CEO of SwoopBolstering Employee Benefits Through Commuter ShuttlesOffering a commute option for employees not only makes the workday far more convenient but also serves as a significant perk for attracting and retaining top talent. Commutes can be a hassle, and public transit doesn't always reach everyone's doorstep. Employer-provided shuttles offer a solution, allowing employees to relax or work during their commute while someone else takes the wheel, improving overall convenience.Technology with Enhanced Insights and ControlDashboards displaying usage, on-time performance, and billing trends provide valuable insights into employee utilization of your corporate shuttle service. Swoop utilizes the latest technology to track all trips and ridership, ensuring transparency and efficiency.Customer Service that Goes Above and Beyond ExpectationsSwoop takes pride in offering an unparalleled dedicated team available 24/7 to ensure that your employee transport program runs seamlessly. With personalized attention from experienced account managers, they work tirelessly to understand your unique needs and tailor services accordingly.Affordability without CompromiseRecognizing the importance of cost-effective solutions, Swoop provides affordable employee shuttling services without compromising on quality. They understand the budget constraints of businesses and strive to deliver value-driven transportation options. Spend less while moving more people.Sustainability at the CoreIn alignment with corporate sustainability goals, Swoop prioritizes environmentally conscious practices. Swoop's fleet and operational strategies are designed to minimize environmental impact, contributing to a greener future. Every employee who takes part in your employee shuttle program removes another vehicle from the road.Photos: (Click photo to enlarge) Source: Swoop Inc.Read Full Story - Leading the Way: Swoop Named Provider of Choice for Employee Shuttling by Fortune 500 & Renowned Technology Companies | More news from this sourcePress release distribution by PRLog

Nasdaq 100 Movers: MRNA, PDD

Nasdaq 100 Movers: MRVL, ILMN

Icahn’s All-In: 3 Stocks Billionaire Carl Icahn Is Betting Big On

Carl Icahn, the corporate raider turned activist investor, has put most of his master limited partnership' portfolio into just three stocks.

Interesting ILMN Put And Call Options For May 17th

Carl Icahn Drops Plans for New Proxy Fight at Illumina

Carl Icahn has decided not to launch a fresh proxy fight at DNA sequencing company Illumina Inc. this year, a person familiar with the matter said.

Exclusive-Icahn drops Illumina board challenge threat, sources say

Activist investor Carl Icahn has dropped a threat to mount a new challenge to Illumina's board, sparing the U.S. gene sequencing company from its second proxy contest in as many years, according to people familiar with the matter. Icahn, who installed one of his nominees to Illumina's board last year through a proxy contest, had said in December he wanted to oust more Illumina directors, blaming them for the company losing three-quarters of its market value because of mismanagement and its soured $7.1 billion acquisition of blood test maker Grail. Icahn saw little value in a new proxy contest after Illumina took steps to comply with antitrust rulings to divest Grail, the sources added.